位置:首页 > 产品库 > Prostaglandin E1-d4
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Prostaglandin E1-d4
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Prostaglandin E1-d4图片
规格:98%
分子量:358.5
包装与价格:
包装价格(元)
50ug询价
100ug询价
500ug询价

An internal standard for the quantification of prostaglandin E1
货号:ajcx23334
CAS:211105-33-8
分子式:C20H30D4O5
分子量:358.5
溶解度:DMF: >100 mg/ml (from PGE1),DMSO: >50 mg/ml (from PGE1),Ethanol: >50 mg/ml (from PGE1),PBS pH 7.2: >1.6 mg/ml (from PGE1)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Prostaglandin E1-d4(PGE1-d4) contains four deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGE1by GC-or LC-mass spectrometry. PGE1is the theoretical cyclooxygenase metabolite of dihomo-γ-linolenic acid (DGLA), but it is virtually undetectable in the plasma of normal humans or other animals.1Its pharmacology includes vasodilation, hypotension, and anti-platelet activities. The IC50of PGE1for the inhibition of ADP-induced human platelet aggregation is 40 nM.2,3The vasorelaxant and anti-hypertensive effects of PGE1are used to treat male erectile dysfunction and to provide emergency vasodilation of the patent ductus arteriosus in infants whose cardiac anomalies require pulmonary shunting for survival.4,5In human males, the intracavernosal effective dose range for PGE1is 2 to 80 µg, and the transurethral range is 125 to 1,000 µg.4


1.Cawello, W., Schweer, H., Dietrich, B., et al.Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunctionJournal of Urology1581403-1407(1997) 2.Kobzar, G., Mardla, V., JÄrving, I., et al.Antiaggregating potency of E-type prostaglandins in human and rabbit plateletsProceedings of the Estonian Academy of Sciences.Chemistry40179-180(1991) 3.Okada, F., Nukada, T., Yamauchi, Y., et al.The hypotensive effect of prostaglandin E1 on hypertensive cases of various typesProstaglandins799-106(1974) 4.Padma-Nathan, H., Hellstrom, W.J.G., Kaiser, F.E., et al.Treatment of men with erectile dysfunction with transurethral alprostadilNew England Journal of Medicine3361-7(1997) 5.Olley, P.M., and Coceani, F.Prostaglandins and the ductus arteriosusAnnual Reviews of Medicine32375-3785(1981)

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024